LightAir has two patented technologies marketed under the brands of IonFlow and CellFlow. IonFlow is based on an innovative development of ionization technology and CellFlow is based on a development of electrostatic filter technology.
LightAir’s products are tested on the market with very good results. The IonFlow technology is alone in the world with scientific evidence to effectively prevent the spread of airborne virus; 2015 was a scientific report published in Nature Scientific Reports after seven year’s of research studies at Karolinska Institutet (KI).
LightAir is listed on Nordic SME Sweden (Nordic Growth Market NGM AB) with the ticker LAIR. The trade in LightAir’s shares can be viewed live on ngm.se.